Effect of Food on Pharmacokinetics of MY008211A Tablets in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 26, 2022

Primary Completion Date

October 23, 2022

Study Completion Date

October 23, 2022

Conditions
Paroxysmal Nocturnal Hemoglobinuria
Interventions
DRUG

MY008211A tablets

A single dose of MY008211A tablet was administered after fasting and high-fat, high-calorie feeding

Trial Locations (1)

410011

The Third Hospital of Changsha, Changsha

All Listed Sponsors
lead

Wuhan Createrna Science and Technology Co., Ltd

INDUSTRY